|
20-12-2018 7:59 EST
| ALK – Financial calendar for the 2019 financial year |
|
14-12-2018 8:33 EST
| ALK upgrades its full-year financial outlook due to accelerated sales |
|
27-11-2018 7:21 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
13-11-2018 10:08 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
9-11-2018 1:33 EST
| Nine-month interim report (Q3) 2018 |
|
5-11-2018 7:29 EST
| Release date of nine-month interim report (Q3) 2018 and audio cast |
|
22-8-2018 14:17 UTC
| ALK submits registration application for tree SLIT-tablet in Europe |
|
15-8-2018 5:37 UTC
| Six-month interim report (Q2) 2018 |
|
9-8-2018 10:21 CEST
| Release date of six-month interim report (Q2) 2018 and audio cast |
|
4-5-2018 7:35 CEST
| Three-month interim report (Q1) 2018 |
|
1-5-2018 9:00 CEST
| Release date of three-month interim report (Q1) 2018 and audio cast |
|
17-4-2018 12:40 CEST
| ALK’s partner for Japan, Torii, secures pricing for new Japanese cedar SLIT-tablet |
|
11-4-2018 12:40 CEST
| ALK announces allergy diagnostic partnership with Rellergen in China |
|
20-3-2018 16:19 CET
| Grant of share options and performance shares to members of the Board of Management and key employees |
|
20-3-2018 15:44 CET
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
16-3-2018 10:54 CET
| Articles of Association |
|
12-3-2018 17:22 CET
| Annual General Meeting in ALK-Abelló A/S held on 12 March 2018 |
|
2-3-2018 16:49 CET
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
21-2-2018 10:00 CET
| New medicine for house dust mite allergic rhinitis and allergic asthma now available in France |
|
16-2-2018 7:00 CET
| ALK’s partner, Torii, gains paediatric approval for the house dust mite SLIT-tablet in Japan |
|
13-2-2018 13:55 CET
| Annual General Meeting in ALK-Abelló A/S on 12 March 2018 |
|
6-2-2018 7:30 CET
| ALK releases its annual report 2017 |
|
30-1-2018 15:54 CET
| Release date of annual report 2017 and audio cast |
|
11-1-2018 9:00 CET
| New Treatment for House Dust Mite (HDM) – Induced Allergic Rhinitis Now Available in US |
